Newsletters

'Welcome to the thirteenth edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'

'Welcome to the twelth edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'

'Welcome to the eleventh edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'

'Welcome to the Tenth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'

'Welcome to the Ninth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'

'Welcome to the Eight edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'

'Welcome to the seventh edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'

'Welcome to the sixth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'

Inside This Issue 

• Cervical Cancer screening in England - The journey so far
• New Assays: For Pregabalin, Gabapentin and Methylphenidate in urine
• How genetic and molecular innovation in pathology will improve NHS outcomes for patients
• Why urine steroid profiling is still the gold standard for identification of steroid-related disorders
• Viapath Career Development Programme
• Genetic analysis of samples from miscarriages usins a new efficient molecular testing strategy 

'Welcome to the fifth edition of pathology@viapath, updating you with what's happening at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining.'

Issue 5 April 2017.pdf

'Welcome to the fourth edition of “pathology@viapath”, an update on a selection of interesting projects and work being performed by Viapath‟s scientists as well as some of the fun events that have taken place.'

'Welcome to the third edition of “pathology@viapath”, an update on a selection of interesting projects and work being performed by Viapath‟s scientists as well as some of the fun events that have taken place.'

Inside This Issue:

• Why the Implementation of a Mandatory Folic Acid Supplementation Should be Opposed in the UK
• Assessment of Promising New Drug for Sickle Cell Disease
• Testing Times to Come? Cancer Research UK's Evaluation of Pathology Capacity Across the UK
• Conference Update: International Society of Neonatal Screening
• Viapath Celebrates World Quality Day
• Guy's Hospital Opens a New Cancer Centre
• Carbohydrate Transferrin: A Marker of Chronic Excessive Alcohol Consumption
• Viapath Leadership Update

'Welcome to the second edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'

Inside This Issue:

• Case Study: Vitamin B12 Deficiency 
• Hepatitis E Virus: An Emerging Zoonosis 
• Improving the Diagnosis of Invasive Fungal Infections in Critically Ill Patients
• Why and How Should Vitamin D2 and D3 be Measued?
• World Thrombosis Day 2016
• Why and How Should Vitamin B12 be Measure?

'Welcome to the first edition of pathology@viapath, updating you with what's happening at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining.'

Inside This Issue:

• Context and Applications of Targeted Genetic Testing
• Zika Virus: News and Views
• Listen to Pathology Podcasts from Viapath's Future Leaders in Innovation Group
• Urgent Urine Porphobilinogen (PBG) Service Introduced
• Modernising Urine Drugs of Abuse Testing